Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
3.460
+0.025 (0.73%)
At close: Jan 8, 2026, 4:00 PM EST
3.371
-0.089 (-2.58%)
After-hours: Jan 8, 2026, 5:25 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $7.84 million as of January 8, 2026. Its market cap has increased by 152.89% in one year.
Market Cap
7.84M
Enterprise Value
1.47M
1-Year Change
152.89%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $7.84M, a decrease of -77.21%. That is a compound annual growth rate of -24.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 7.80M | 20.00% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 942.18B |
| Johnson & Johnson | 495.98B |
| AbbVie | 392.02B |
| UnitedHealth Group | 317.39B |
| AstraZeneca | 280.51B |
| Merck & Co. | 270.12B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |